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Promotion of hepatic metastases by liver resection in the rat
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First Department ofSurgery, Kumamoto University Medical School, Kumamoto 860, Japan.
Summary In the early period following radical hepatectomy for hepatoma, recurrences in the remaining liver
are frequently found. In regenerating liver, implantation and growth of tumour cells released into the portal
system during surgical treatment might be promoted. We examined the relationship between liver regeneration
and the formation of metastases following hepatic resection. Intraportal injections of rat ascites containing
hepatoma AH130 cells at a concentration of 1 x IO' cells 0.2 ml-l were made at various periods following two
thirds liver resection in rats. Tumour cell injections immediately at 24 h after surgery resulted in an increased
number of hepatic metastases compared with control animals. Tumour cell injections 2 weeks after hepatec-
tomy, however, had no significant difference in effect compared with control rats. In contrast, tumour cells
injected immediately after removal of half of the caudate lobe resulted in the same number of metastases as
control animals. These results demonstrate that the number of artificially induced hepatic metastases was
increased during an initial period of active liver regeneration and was proportional to the volume of
hepatectomy.
The effect of 5-fluorouracil (5FU) or mitomycin C (MMC) as inhibitors of hepatic regeneration on liver
metastasis after hepatectomy was studied. The administration of 5FU (20mg kg-') or MMC (0.2 mg kg-')
immediately, 24 and 48 h after hepatectomy resulted in a marked reduction in metastatic lesions. The
administration of 5FU caused delays in weight gain and decreases in the wet weight of remaining liver, while
MMC had no effect on either. Accordingly, results of 5FU administration may be due to inhibitory effects on
liver regeneration whilst that of MMC administration may be due to cytocidal antitumour effect. The effect of
OK-432 as an immunoactivator on the implantation and growth of tumour cells in regenerating liver was also
studied. Pretreatment with OK-432, 0.5 mg intraperitoneally on 7 consecutive days, had no effect on hepatic
metastases.
The pathophysiology of liver regeneration may enhance hematogenous hepatic metastasis and release of
tumour cells during surgical manipulation may represent an important cause of recurrence following hepatic
resection.
Recent advances in preoperative diagnostic techniques and
intraoperative ultrasonography have provided a greater
ability to determine the number, location, and extent of liver
lesions (Kanematsu et al., 1985; Makuuchi et al., 1987).
Despite their application to the surgical resection of liver
malignancies, however, recurrences are frequently found in
the early postoperative period. It as yet remains unclear
whether such lesions are due to pre-existing microscopic
disease, result from surgical manipulation, or both.
According to Okuda et al. (1977), intrahepatic arteriopor-
tal anastomosis is demonstrated in 63.2% of patients with
hepatocellular carcinoma, and retrograde flow of the portal
vein trunk is seen in 25.4% as revealed by angiography.
Therefore, tumour cell release into the portal vein during
surgical treatment for liver malignancies may increase the
metastasis of tumour to the liver. In particularly, in re-
generating liver, implantation and growth of tumour cells
released into the portal system might be promoted. Therefore
we studied the effects of liver resection and regeneration on
experimentally-induced hepatic metastases.
Materials and methods
Male HOS-Donryu rats (JAPAN SLC, Inc., Hamamatsu,
Japan) weighing 180-270 g were used in all experiments and
maintained on a standard rat pellet diet with tap water ad
libitum.
AH130 hepatoma cells (Sasaki Institute, Tokyo, Japan)
used for intraportal injections were maintained by intra-
peritoneal passage every 7 days. Ascites obtained on the
seventh day was used in experiments. A suspension of
AH130 tumour cells was prepared in Hanks' balanced salts
solution at a concentration of 1 x 105 cells 0.2 ml' prior to
injection. More than 90% of tumour in ascites consisted of
single cells.
The drugs used in this study were OK-432 (Picibanil;
Chugai Pharmaceutical Co. Ltd., Tokyo, Japan), 5-fluor-
ouracil (5FU) and mitomycin C (MMC) (both from Kyowa
Hakko Kogyo Co. Ltd., Tokyo, Japan).
Questions investigated in our research entailed six (I-VI)
separate experimental designs, each design composed of both
experimental and control animals. The first experimental
design (I) examined the role of metastatic dissemination dur-
ing the initial postoperative period of active hepatic regenera-
tion after partial hepatectomy (two thirds resected) in the rat.
Animals undergoing partial hepatectomy were injected with
tumour cell suspensions immediately after (group A; n = 8)
and 24 h (group B; n = 7) following surgery when hepatic
regeneration was most active. Control animals (group C;
n = 7) did not undergo liver resection, but rather, received
tumour cells injections via the portal vein after blocking
blood flow to the segment resected in groups A and B.
Similar in design, experiment II focused on metastatic
dissemination at the time of accomplishment of hepatic
regeneration in rat. Animals received tumour cell injections,
as above, 2 weeks following partial hepatic resection when
hepatic regeneration had been already accomplished (group
D; n = 5). As a control, nonhepatectomised rats received
injections into whole liver (group E; n = 7).
In contrast to the above designs, the influence of the extent
of liver resection on hepatic metastases were investigated
(III). For comparison to the above groups, rats underwent
minimal hepatectomy immediately prior to tumour cell injec-
tions (group F; n = 9). Tumour cell injections into animals
with intact livers were performed as a control (group G;
n = 9).
In the last three experiments, 5FU (IV) and MMC (V) as
inhibitors of hepatic regeneration and OK-432 (VI) as
immunoactivator to prevent immunodepression of the hepa-
tectomy were studied for their ability to prevent hepatic
Correspondence: J. Mizutani, First Department of Surgery, Kuma-
moto University Medical School, 1-1-1 Honjo, Kumamoto 860,
Japan.
Received 22 July 1991; and in revised form 18 December 1991.
'." Macmillan Press Ltd., 1992 Br. J. Cancer (1992), 65, 794-797PROMOTION OF HEPATIC METASTASES 795
metastases in animals undergoing partial hepatectomy. Those
receiving 5FU (group H; n = 10) and MMC (group J; n = 10)
received intravenous doses of 20 mg kg-' and 0.2 mg kg-',
respectively, immediately, 24 and 48 h postoperatively.
Animals receiving OK-432 (group L; n = 8) were given 0.5 mg
by intraperitoneal injection on each of the 7 days prior to
surgery. Control groups I (n = 9), K (n = 10) and M (n = 9)
received 0.2 ml of a 0.9% sodium chloride (NaCl) solution in
an analogous fashion to groups receiving 5FU, MMC and
OK-432, respectively.
Laparotomies were performed using sterile technique under
light ether anaesthesia. Injections of tumour cells into the
portal vein were carried out slowly using a 27-gauge needle.
Partial hepatectomy (two thirds resected) was performed as
described by Higgins and Anderson (1931). Minimal hepatec-
tomy consisted of removal of half of the caudate lobe (about
5% hepatectomy).
5FU (20 mg kg-') and MMC (0.2 mg kg-') were also dis-
solved in 0.2 ml of a 0.9% NaCl solution and administered
intravenously (tail vein) immediately, 24 and 48 h after hepa-
tectomy and tumour cell inoculation. OK-432 (0.5 mg) was
dissolved in 0.2 ml of a 0.9% NaCl solution and administer-
ed to rats intraperitoneally on the 7 consecutive days pre-
ceeding hepatectomy and tumour cell inoculation.
All animals were sacrificed 10 days after tumour cell inocu-
lation and their livers and lungs promptly removed and fixed
in 10% formaldehyde. Metastases on the surface of the liver
and lung lobes were counted for comparison between experi-
mental groups. Histological examination was performed
using haematoxylin-eosin stain. Statistical analyses were per-
formed using the Student's t-test with a P value of less than
0.05 considered to be significant.
Results
Hepatic metastases were observed macroscopically and
microscopically 10 days after tumour cell inoculation. No
pulmonary metastatic foci were detected microscopically in
any experiments.
The influence of partial hepatectomy on growth of hepatic
metastases is shown in Tables I and II. Groups A and B had
significantly larger numbers of metastatic lesions than group
C (control group), but there was no significant difference
between groups D and E.
The influence of minimal hepatectomy on growth of hepa-
tic metastases is shown in Table III. There was no significant
difference between groups in the incidence and the number of
metastatic nodules.
Table I Influence of partial hepatectomy on growth of hepatic
metastases (I)
Hepatic metastases
Group Incidence No. ofmetastases-a
A (n=8) 8/8 150.5±111.5b
B (n=7) 7/7 150.0±131.9b
C (n=7) 6/7 17.7±9.8
aThe mean number of metastases in the livers where there was
macroscopic evidence ofmetastases. bp<0.05 vs Group C. Each value
is expressed as the mean ±s.d.
Table II Influence of partial hepatectomy on growth of hepatic
metastases (II)
Hepatic metastases
Group Incidence No. ofmetastasesa
D (n = 5) 3/5 14.0±12.3b
E(n=7) 4/7 14.4±17.8
aThe mean number of metastases in the livers where there was
macroscopicevidence ofmetastases. bp, notsignificant vs group E. Each
value is expressed as the mean ±s.d.
Table III Influence of minimal hepatectomy on growth of hepatic
metastases (III)
Hepatic metastases
Group Incidence No. ofmetastasesa
F(n=9) 6/9 15.5±14.7b
G (n=9) 6/9 22.5±26.1
aThe mean number of metastases in the livers where there was
macroscopic evidence of metastases. bp, not significant vs Group G.
Each value is expressed as the mean±s.d.
The effect of 5FU treatment is shown in Table IV. Group
H (treated with 5FU) had a significantly smaller number of
metastatic nodules as compared with group I (control group).
Group H rats were notable for significant delays in body
weight gain and significant decreases in the wet weight of the
remaining liver as compared with group I.
As regards MMC treatment (Table V), the number of
metastatic foci in group J (MMC treated) was smaller than
that in group K (control group). The difference between these
two groups was highly statistically significant (P<0.001).
Body weight and wet weight of the remaining liver were not
significantly different between groups.
The effect of OK-432 pretreatment on the occurrence of
hepatic metastases in rats subjected to partial hepatectomy is
shown in Table VI. There was no significant difference
between groups in the incidence and the number of hepatic
metastases. Similarly, no significant difference in body weight
was observed between groups. In group L (treated with
OK-432), however, significant increases in the wet weight of
the remaining liver were noted as compared with group M
(control group).
Discussion
Recurrences of intrahepatic malignancy following hepatec-
tomy for primary and secondary liver cancers are found
frequently and represent the most problematic aspect of sur-
gical treatment. Kanematsu et al. (1988) reported metastatic
recurrence in 41 of 121 patients who underwent curative
resection for primary hepatocellular carcinoma, and in 33 of
these 41 patients (82%) recurrences were intrahepatic. Naga-
sue et al. (1982) identified liver recurrences as falling into
four patterns; (1) multiple disseminated lesions, probably due
to surgical manipulation, (2) residual tumour at the site of
the resected stump, (3) erroneous preoperative diagnosis and
(4) metachronous occurrence of tumours.
Hepatic regeneration following partial hepatectomy is a
specific phenomenon and may play an important role in the
formation of metastatic lesions following hepatic resection.
Gershvein (1963) reported that tumour growth in the remain-
ing liver was accelerated by hepatectomy. Paschkis et al.
(1955) reported that the growth of tumour implanted sub-
cutaneously at the time of partial hepatectomy was greater
than in control animals. Mabuchi (1985) has shown that liver
regeneration influences the growth of intrahepatic, but not
extrahepatic tumour. Our studies indicated that the number
of artificially induced hepatic metastases was increased dur-
ing a period of active liver regeneration and was increased in
proportion to the volume of the liver removed. There were
few reports regarding these results. Fisher and Fisher (1959)
also reported promotion of hepatic metastases in rats par-
tially hepatectomised immediately after intraportal injection
of Walker carcinosarcoma 256 tumour cells. These observa-
tions suggest that the pathophysiology of liver regeneration
may enhance artificially induced hepatic metastases. There
have been few studies of the relationship between hepatic
regeneration and metastases.
It seems that hepatic metastases were promoted in accor-
dance with the degree of activeness of hepatic regeneration.
Therefore, we investigated whether hepatic metastases were
suppressed by inhibitor of hepatic regeneration. Administra-
tion of 5FU (20 mgkg-') or MMC (0.2 mgkg-') after par-796 J.MIZUTANI et al.
Table IV The effect of5FU ongrowth ofhepatic metastases inpartial
hepatectomy (IV)
Group H Group I
(treated, n = 10) (untreated, n = 9)
Body weight (g)
at surgery 217.0±19.0 218.3±11.3
at autopsy 234.3±20.5b 259.8± 17.0
Wet weight of liver (g) 10.97±1.06b 13.08±1.47
Hepatic metastases
Incidence 4/10 8/9
No. of metastasesa 29.0±26.8C 175.9± 139.8
aThe mean number of metastases in the livers where there was
macroscopic evidence ofmetastases. bp<0.01 vs Group I. CP<0.05 vs
Group I. Each value is expressed as the mean±s.d.
Table V TheeffectofMMC ongrowth ofhepaticmetastases inpartial
hepatectomy (V)
Group J Group K
(treated, n = 10) (untreated, n = 10)
Body weight (g)
at surgery 257.0± 11.8 256.6±8.15
at autopsy 276.5±21.2 286.1 ±21.2
Wet weight of liver (g) 12.60± 1.39 13.58± 1.22
Hepatic metastases
Incidence 5/10 9/10
No. ofmetastasesa 11.4± 13.Ob 167.6±55.5
aThe mean number of metastases in the livers where there was
macroscopic evidence ofmetastases. bp<0.001 vsgroup K. Each value
is expressed as the mean±s.d.
Table VI The effect of OK-432 on growth of hepatic metastases in
partial hepatectomy (VI)
Group L Group M
(treated, n = 8) (untreated, n = 9)
Body weight (g)
at surgery 199.0±9.1 200.3±9.1
at autopsy 240.6± 12.7 230.7± 14.8
Wet weight ofliver (g) 13.33 ±l.l9b 11.86±0.76
Hepatic metastases
Incidence 7/8 9/9
No. ofmetastasesa 128.6±92.0 192.4± 122.6
aThe mean number of metastases in the livers where there was
macroscopic evidence ofmetastases. bp<0.05 vs Group M. Each value
is expressed as the mean±s.d.
tial hepatectomy resulted in marked reduction in hepatic
metastases. 5FU impaired liver regeneration as evidenced by
a lower wet weight of the remaining liver, whereas MMC
administration had little effect. Nagasue et al. (1978) and
Kohno et al. (1984) also demonstrated that 5FU administra-
tion shortly after hepatectomy inhibited liver regeneration in
rats. In addition, Mabuchi (1985) reported that MMC
administration (0.4 mgkg-' day-') for the 4 days following
hepatectomy resulted in only transient suppression of hepatic
regeneration. The inhibitory effect of 5FU on hepatic metas-
tases may be due to suppression of hepatic regeneration. The
effect of MMC, however, may not be due to minimal tran-
sient suppression of hepatic regeneration, but to a direct
cytocidal effect.
However, it is not clear if the pathophysiology of liver
regeneration is effective in the initial implantation or in the
subsequent growth of tumour cells during the formation of
metastatic lesions. Trauma has a well-known favourable
effect on cell lodgement (Fisher & Fisher, 1959; Skolnik et
al., 1980). This may be through the induction of microcir-
culatory disturbances that enhance vascular entrapment of
circulating cells (Skolnik et al., 1980). A simple mechanical
cause, however, seems unlikely in the present case. Tumour
cell implantation and growth could be influenced by the host
immune status (Fidler et al., 1977), and partial hepatectomy
might modulate host immune response to the inoculated cells
(Ono et al., 1986). We therefore studied the effect on the
formation of hepatic metastases of OK-432 which activates
macrophages non-specifically in hosts (Ishii et al., 1976),
increases overall function of the reticuloendothelial system
(Oshimi et al., 1980), and stimulates non-specific killer cells
and the function of T-lymphocytes (Kai et al., 1979). Naka-
gawa et al. (1988) indicated that OK-432 activated not only
non-specific immunity, but also reticuloendothelial function
in rats subjected to hepatectomy. Furthermore, our collea-
gues, Yamashita et al. (1986) reported that perioperative
immune activation with OK-432 pretreatment reduced the
number of liver metastases in rats injected with AH130
tumour cells. In the present study, OK-432 pretreatment
using the same experimental design did not reduce the inci-
dence or the number of artificially induced hepatic metas-
tases. Therefore, the promotion of hepatic metastases in
regenerating liver may not be due to a reduction in immuno-
logical and reticuloendothelial function. The release of
growth factors by hepatocytes and other cells (Earp &
O'Keefe, 1981; Mead & Fausto, 1989; Nakamura et al.,
1984) may be one of the major reasons why tumour growth
is potentiated in the resected liver. Further studies into the
precise mechanism whereby the implantation and the growth
of hematogenous hepatic metastases are promoted after
hepatectomy will be necessary. Our present study suggests
that the pathophysiology of liver regeneration may enhance
hepatic metastases and release of tumour cells during surgical
manipulation may represent an important cause of recurrence
following hepatic resection.
With regard to the prevention of hepatic recurrences due
to hematogenous metastasis during surgical manipulation,
our studies present some important problems in the treat-
ment of hepatobiliary cancer. The initial postoperative period
is not only critical for formation of metastatic lesions, but is
also important for the regeneration of resected liver.
Although the use of anticancer drugs during this period
might prevent implantation and growth of tumour cells, these
drugs might also inhibit hepatic regeneration. Our results of
administration of cytocidal anticancer agents like MMC
indicate that such an approach may be useful as perioper-
ative adjuvant chemotherapy after extensive hepatic resec-
tion. Certainly the next step would be to study whether
experimental adjuvant chemotherapies have merit in the
prevention of recurrences clinically. Secondly, this study has
implications for the extent of liver resection for malignancy.
The extent of resection has previously been predicated so as
to prevent stump recurrences and/or hepatic failure after
hepatectomy. Given the results of our study which showing
an increased risk for experimentally induced hepatic metas-
tases in partial as compared with minimal hepatectomy, the
extent of liver resection may require future consideration in
the optimisation of the surgical treatment of hepatic malig-
nancies.
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